SABS · SAB Biotherapeutics, Inc. · Fails to Deliver
$3.20
+0.13 (+4.07%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$285.96M
Shares
90.99M
Volume · Oct 28
235.28K
Avg daily vol (3M)
528.92K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-04 | 2,043 | $3.72 | $7,600 |
| 2026-09-02 | 319 | $3.70 | $1,180 |
| 2026-08-31 | 3 | $3.79 | $11 |
| 2026-08-26 | 7,996 | $3.81 | $30,465 |
| 2026-08-21 | 9,220 | $3.70 | $34,114 |
| 2026-08-19 | 99,801 | $3.79 | $378,246 |
| 2026-08-18 | 60,378 | $3.77 | $227,625 |
| 2026-08-17 | 49,799 | $3.70 | $184,256 |
| 2026-08-14 | 50,044 | $3.75 | $187,665 |
| 2026-08-13 | 22,799 | $3.80 | $86,636 |
| 2026-08-12 | 48,130 | $3.76 | $180,969 |
| 2026-08-11 | 7 | $3.78 | $26 |
| 2026-08-07 | 4,325 | $3.85 | $16,651 |
| 2026-08-05 | 21 | $3.85 | $81 |
| 2026-08-04 | 1 | $3.79 | $4 |
| 2026-08-03 | 10,902 | $3.57 | $38,920 |
| 2026-07-31 | 3,652 | $3.56 | $13,001 |
| 2026-07-29 | 6,059 | $3.45 | $20,904 |
Showing 1–18 of 18 settlements